Skip to main content

Table 2 The most significant BP terms based on P-value*

From: Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis

BP terms

P-value

Count

geneID

primary alcohol metabolic process

3.54E-10

12

AKR1B10, AKR1C3, SULT2A1, SCNN1B, AKR1C2, CYP3A5, CYP2C18, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

hormone metabolic process

4.95E-10

16

AKR1B10, AKR1C3, SULT2A1, SPP1, SCNN1B, KLK6, FOXA1, AKR1C2, CYP3A5, CYP2C18, CTSL, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

tissue homeostasis

1.32E-09

17

VSIG1, CLDN18, SLC28A2, CLDN1, TFF2, TFF1, SPP1, SLC12A2, PTGS2, PIGR, MUC6, GCNT2, FOXC1, CLDN3, CDH3, CA2, ALDH1A1

olefinic compound metabolic process

3.77E-09

13

AKR1B10, AKR1C3, SCNN1B, PTGS2, GSTA1, AKR1C2, CYP3A5, CYP2C18, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

Digestion

1.08E-08

12

CAPN8, VSIG1, GKN1, CAPN9, TFF2, TFF1, SST, PGC, MUC6, AKR1C2, CHRM3, CCKBR

cellular hormone metabolic process

1.08E-08

12

AKR1B10, AKR1C3, SPP1, SCNN1B, AKR1C2, CYP3A5, CYP2C18, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

anatomical structure homeostasis

1.42E-08

17

VSIG1, CLDN18, SLC28A2, CLDN1, TFF2, TFF1, SPP1, SLC12A2, PTGS2, PIGR, MUC6, GCNT2, FOXC1, CLDN3, CDH3, CA2, ALDH1A1

retinol metabolic process

2.82E-08

8

AKR1B10, AKR1C3, CYP3A5, CYP2C18, ALDH1A1, ADH7, ADH1C, ADH1A

retinoid metabolic process

9.98E-08

9

AKR1B10, AKR1C3, CYP3A5, CYP2C18, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

diterpenoid metabolic process

1.87E-07

9

AKR1B10, AKR1C3, CYP3A5, CYP2C18, AKR1C4, ALDH1A1, ADH7, ADH1C, ADH1A

  1. *P-value < 0.05 was considered significant